For over 30 years, EUROMONEY has been the benchmark for awards in the European banking industry. In order to recognize the many independent wealth managers/EAM/MFOs ...
DENVER, CO / ACCESS Newswire / March 31, 2025 / Solitario Resources Corp. ("Solitario") (NYSE American:XPL)(TSX:SLR) is pleased to report President and CEO Chris Herald will provide a live webcast pre ...
Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) today reported its operational and financial results for 2024. Matthew Wilcox, Managing Director ...
TCL SunPower Global, a new energy business unit within TCL Group, was announced today to commence its business operations as a leading provider of ...
BURLESON, TX / ACCESS Newswire / March 31, 2025 / Sadot Group Inc. (Nasdaq:SDOT) ("Sadot Group", "Sadot" or the "Company"), a rapidly growing player in the global agri-food supply chain, is proud to a ...
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / SILVER X MINING CORP. (TSXV:AGX)(OTCQB:AGXPF)(F:AGX) ("Silver X" or the "Company") announces that it has granted 450,000 restricted share units with ...
MEXC, a leading global cryptocurrency exchange, confirms the upcoming listing of GUNZ (GUN) on March 31, 2025(UTC). To celebrate this listing ...
FB Financial Corporation ("FB Financial") (NYSE: FBK), the parent company of FirstBank, and Southern States Bancshares, Inc. ("Southern ...
The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical b ...
Sets company first-month sales record by combining the series' appeal with new elements Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of Monster Hunter Wilds, released on February ...
Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term shel ...
BEIJING, CHINA / / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results